Psilocybin Therapy in Seattle
Psilocybin is a naturally occurring compound found in certain species of mushrooms, used ceremonially by Indigenous cultures for thousands of years and now one of the most actively researched substances in modern psychiatry. Over 134 psilocybin clinical trials have been registered over the past two decades, spanning conditions from depression and anxiety to addiction and end-of-life distress.
Psilocybin for Depression
The most compelling results have emerged in psilocybin therapy for depression. Studies have demonstrated sustained remission in over 50% of patients at six months, a striking figure for a population that has often cycled through multiple medications and therapies without lasting relief. Notably, meaningful reductions in depressive symptoms can appear after just two psilocybin sessions, with effects remaining significant six months later in patients with treatment-resistant depression.
Psilocybin for Anxiety, Substance Use Disorder and End-of-Life Distress
Beyond depression, psilocybin has shown meaningful results for existential distress and anxiety in people facing terminal illness (Griffiths et al., 2016), alcohol use disorder, and tobacco dependence. Phase 3 registration trials are currently underway for both major depressive disorder and treatment-resistant depression, bringing psilocybin closer to broader clinical availability.
How Psilocybin Works Differently
Psilocybin appears to catalyze lasting shifts in how the brain processes information, emotion, and self-perception. Not through daily maintenance, but through a single, profound opening. What the experience reveals can be beautiful, surprising, and sometimes vast or disorienting. Having someone present who can track what is moving through, stay steady when things get hard, and help what arose find language and meaning afterward can help how the healing lands.
In one of the most striking recent cases, a woman in her 80s with advanced Alzheimer’s disease who had not spoken beyond single words in five years temporarily regained speech, mobility, and emotional expressiveness following a psilocybin experience, as documented in a 2026 case report published in Frontiers in Neuroscience. While researchers are careful to note this is a single case requiring much more study, it points to something remarkable: the possibility that psilocybin may reach parts of the brain and self that conventional medicine had given up on.
The information on this page reflects current research in psychedelic medicine and is offered purely for educational purposes, not as medical or psychiatric advice. I am not a licensed therapist or healthcare provider, and nothing here should replace professional medical care.
If you’re curious about what preparation, journey support, or integration might look like for you, I’d love to hear from you.